JDD Corner

JDD Corner

Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!

Video Abstracts

Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!

NEW! VIDEO ABSTRACT

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disorder characterized by blistering of the skin and mucous membranes. Current pathophysiology implicates autoantibodies targeting type VII collagen, which serves as a crucial component of anchoring fibrils that attach the epidermis to the dermis. Management of EBA remains challenging and relies on a combination of anti-inflammatory, immunosuppressive, and immunomodulating agents.

NEW! VIDEO ABSTRACT

Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials

Atopic dermatitis (AD) is a chronic inflammatory skin disorder afflicting approximately 31.6 million people in the United States, with a disproportionate impact on racial and ethnic minorities who often experience greater disease severity. This study aims to analyze racial and ethnic representation in recent atopic dermatitis clinical trials.

NEW! VIDEO ABSTRACT

Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory Peptide That Demonstrates Anti-Aging, Firming, and Lifting Benefits

 There is continuous demand for safe, effective cosmetic ingredients to treat the signs of aging skin, including fine lines, wrinkles, brown spots, discoloration, laxity, and sagging. While there are a plethora of cosmeceutical peptides, few combine anti-aging and anti-inflammatory benefits with small size.

NEW! VIDEO ABSTRACT

New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model

The greatest risk factor for skin cancer is exposure to ultraviolet (UV) rays of the sun. Among the three types of solar radiation (UVA, UVB, UVC), UVB rays are most commonly associated with skin cancer. UVB exposure promotes the formation of cyclobutane pyrimidine dimers (CPDs) in the DNA of cells in the epidermal skin layers, which can lead to mutations as DNA repair machinery attempts to repair the damage. 

Watch Video

VIDEO ABSTRACT

GLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations

The glucagon-like peptide-1 receptor agonists (GLP1RAs) are a widely popularized drug class due to their notable success in promoting weight loss. The GLP1RAs, dulaglutide, exenatide, semaglutide, liraglutide, tirzepatide, and lixisenatide are FDAapproved for use in the treatment of obesity and type 2 diabetes mellitus (DM), particularly to reduce cardiovascular risk and improve glycemic control.1,2,3 GLP1RAs work by mimicking glucagon-like peptide-1 (GLP-1), an incretin, that functions to subdue appetite, delay gastric emptying, and regulate homeostasis of glucose.

VIDEO ABSTRACT

Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

The role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated skin target site to support patient adherence and satisfaction, ideally without skin irritation. To achieve a pharmacological effect, the drug must be able to penetrate through the stratum corneum (SC) into the viable epidermis and dermis. The skin barrier is composed of terminally differentiated keratinocyte cells (corneocytes) and lipid lamellae, which prevent the movement of water out of the skin.

View All Video Abstracts

Author Spotlight

Click here to watch Dr. Rogers’ video spotlight for his May article, “Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis”.

Trending Articles

Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

utilizes PubMed and SCOPUS to identify articles addressing the treatment of cylindrocarcinoma through excision and/or MMS from inception to May 2024.

Read More

Topical Corticosteroid Potencies: Reimagining A New Universal Classification System

aims to assess the factors that go into classifying TCS based on their potency and to propose a universal classification system.

Read More

Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel

shares eight developed consensus statements related to the efficacy and safety of HHIs for laBCC.

Read More

Clinical Features and the Management of Drug-Induced Eruptive Keratoacanthoma and Squamous Cell Carcinoma: A Review of 172 Cases

identifies significant differences in the clinical presentation of eruptive KA/SCC between drug etiologies.

Read More

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Results from a 6-Month Open-Label Study

explores long-term efficacy, safety, and tolerability of CAB gel in participants with moderate or severe acne.

Read More

Recent News

Editor's Picks

May 28, 2025

Topical Corticosteroid Potencies: Reimagining A New Universal Classification System

May 27, 2025

The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis discusses the results of 2,380 patients who underwent same-day reconstruction for high- and moderate-risk area defects.

Video Pearls

Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea

Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.

Tips for Providing Better Atopic Dermatitis Care

With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.

Acne and Diet

Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”

Crushing It In The Capital: Lessons From Residency Translated

Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters. 

New Innovations in Hyperpigmentation

Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.